Baroness Finlay of Llandaff

Alert Sample

View the Parallel Parliament page for Baroness Finlay of Llandaff

Information between 31st August 2024 - 9th November 2024

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.

Division Votes
6 Nov 2024 - Passenger Railway Services (Public Ownership) Bill - View Vote Context Baroness Finlay of Llandaff voted Aye and in line with the House One of 8 Crossbench Aye votes vs 12 Crossbench No votes Tally: Ayes - 187 Noes - 132

Speeches
Baroness Finlay of Llandaff speeches from: Olympic and Paralympic Games: Team GB Baroness Finlay of Llandaff contributed 1 speech (93 words) Monday 4th November 2024 - Lords Chamber
Baroness Finlay of Llandaff speeches from: Arrangement of Business Baroness Finlay of Llandaff contributed 1 speech (40 words) Thursday 31st October 2024 - Grand Committee
Baroness Finlay of Llandaff speeches from: Special Educational Needs Baroness Finlay of Llandaff contributed 1 speech (92 words) Thursday 24th October 2024 - Lords Chamber Department for Education
Baroness Finlay of Llandaff speeches from: Hospices: Funding Baroness Finlay of Llandaff contributed 1 speech (479 words) Thursday 24th October 2024 - Lords Chamber Department of Health and Social Care
Baroness Finlay of Llandaff speeches from: Biocidal Products: Hand and Body Washes Baroness Finlay of Llandaff contributed 1 speech (139 words) Wednesday 16th October 2024 - Lords Chamber Department for Business and Trade
Baroness Finlay of Llandaff speeches from: NHS Hospitals: Apheresis Baroness Finlay of Llandaff contributed 1 speech (91 words) Wednesday 9th October 2024 - Lords Chamber Department of Health and Social Care
Baroness Finlay of Llandaff speeches from: Bread and Flour Regulations 1998 Baroness Finlay of Llandaff contributed 1 speech (115 words) Wednesday 11th September 2024 - Lords Chamber Department of Health and Social Care
Baroness Finlay of Llandaff speeches from: Government Policy on Health Baroness Finlay of Llandaff contributed 1 speech (112 words) Tuesday 10th September 2024 - Lords Chamber Department of Health and Social Care
Baroness Finlay of Llandaff speeches from: Support for Infants and Parents etc (Information) Bill [HL] Baroness Finlay of Llandaff contributed 1 speech (1,134 words) 2nd reading Friday 6th September 2024 - Lords Chamber Department of Health and Social Care
Baroness Finlay of Llandaff speeches from: Lithium-ion Battery Safety Bill [HL] Baroness Finlay of Llandaff contributed 1 speech (1,321 words) 2nd reading Friday 6th September 2024 - Lords Chamber Department for Business and Trade
Baroness Finlay of Llandaff speeches from: Independent Schools: VAT Exemption Baroness Finlay of Llandaff contributed 1 speech (574 words) Thursday 5th September 2024 - Lords Chamber Department for Education

Written Answers
Home Care Services: Prescriptions Asked by: Baroness Finlay of Llandaff (Crossbench - Life peer) Monday 9th September 2024 Question to the Department of Health and Social Care: To ask His Majesty's Government what evidence they have of unrelieved symptom distress in patients when care assistants are prohibited from administering prescribed medication at home; and how many errors have been recorded when care assistants have administered prescribed breakthrough medication in the patient's home. Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care) Good practice for homecare is set out in the National Institute for Health and Care Excellence’s (NICE) guidance, which can be found on the NICE’s website, in an online only format. Services need to submit statutory notifications to the Care Quality Commission (CQC) when a medicines incident reaches a specific threshold. This includes an allegation of abuse, the death of a person, an incident reported to or investigated by the police, or a serious injury. Data on anything that does not constitute the CQC threshold is not held by the CQC, but may be held by individual providers as a recorded incident.
Cancer: Medical Treatments Asked by: Baroness Finlay of Llandaff (Crossbench - Life peer) Friday 11th October 2024 Question to the Department of Health and Social Care: To ask His Majesty's Government what steps they are taking to secure funding for and expand access to minimally invasive cancer therapies approved by the National Institute for Health and Care Excellence across NHS Trusts. Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care) Both NHS England and integrated care boards (ICBs) are required to put in place access for any treatment that carries a positive recommendation from the Technology Appraisal programme, operated by the National Institute for Health and Care Excellence (NICE). Where treatments are approved by NICE through the Technology Appraisals programme, the National Health Service is required to fund and make them available within agreed timescales, which vary by technology. Implementation of any NICE approvals will be supported by the service readiness assessment and the development of additional capacity where necessary. During 2024/25, NHS England will continue to support all ICBs in integrating the planning and commissioning of suitable specialised services with their wider population-level commissioning responsibilities, in line with their individual timeline for delegation. Service Development Funding (SDF) is available to support Cancer Alliances to deliver the priorities set out in the 2024/25 NHS Operational Planning Guidance; £266 million in SDF is being provided to Cancer Alliances in 2024/25. Funding comprises two allocations: place-based, provided to all Alliances on a fair shares basis; and, targeted, provided to a selection of Alliances for agreed targeted projects. Cancer SDF is provided to Cancer Alliances via their lead ICBs to enable them to deliver on NHS-wide priorities for cancer, in line with their local delivery plans which are included in their funding agreement.
Cancer: Medical Treatments Asked by: Baroness Finlay of Llandaff (Crossbench - Life peer) Wednesday 16th October 2024 Question to the Department of Health and Social Care: To ask His Majesty's Government what steps they are taking to ensure that NHS Trusts have the necessary funding and trained staff to deliver minimally invasive cancer therapies. Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care) The adoption of new treatments, including increasing the number and availability of minimally invasive cancer treatments, into the National Health Service in England is generally the result of National Institute for Health and Care Excellence (NICE) guidance and commissioner decisions. Both NHS England and the integrated care boards (ICBs) are required to put in place access for any treatment that carries a positive recommendation from the Technology Appraisal programme, operated by the NICE. Where treatments are approved by the NICE through the Technology Appraisals programme, the NHS is required to fund and make them available within agreed timescales, which vary by technology. Implementation of any NICE approvals will be supported by the service readiness assessment and the development of additional capacity where necessary. During 2024/25, NHS England will continue to support all ICBs in integrating the planning and commissioning of suitable specialised services with their wider population-level commissioning responsibilities, in line with their individual timeline for delegation. We are committed to training the staff we need to get patients seen on time. The Government will make sure the NHS has the staff it needs to be there for all of us when we need it, including cancer patients.

Written Answers

Home Care Services: Prescriptions
Asked by: Baroness Finlay of Llandaff (Crossbench - Life peer)
Monday 9th September 2024

Question to the Department of Health and Social Care:

To ask His Majesty's Government what evidence they have of unrelieved symptom distress in patients when care assistants are prohibited from administering prescribed medication at home; and how many errors have been recorded when care assistants have administered prescribed breakthrough medication in the patient's home.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

Good practice for homecare is set out in the National Institute for Health and Care Excellence’s (NICE) guidance, which can be found on the NICE’s website, in an online only format.

Services need to submit statutory notifications to the Care Quality Commission (CQC) when a medicines incident reaches a specific threshold. This includes an allegation of abuse, the death of a person, an incident reported to or investigated by the police, or a serious injury.

Data on anything that does not constitute the CQC threshold is not held by the CQC, but may be held by individual providers as a recorded incident.

Cancer: Medical Treatments
Asked by: Baroness Finlay of Llandaff (Crossbench - Life peer)
Friday 11th October 2024

Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to secure funding for and expand access to minimally invasive cancer therapies approved by the National Institute for Health and Care Excellence across NHS Trusts.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

Both NHS England and integrated care boards (ICBs) are required to put in place access for any treatment that carries a positive recommendation from the Technology Appraisal programme, operated by the National Institute for Health and Care Excellence (NICE).

Where treatments are approved by NICE through the Technology Appraisals programme, the National Health Service is required to fund and make them available within agreed timescales, which vary by technology. Implementation of any NICE approvals will be supported by the service readiness assessment and the development of additional capacity where necessary.

During 2024/25, NHS England will continue to support all ICBs in integrating the planning and commissioning of suitable specialised services with their wider population-level commissioning responsibilities, in line with their individual timeline for delegation. Service Development Funding (SDF) is available to support Cancer Alliances to deliver the priorities set out in the 2024/25 NHS Operational Planning Guidance; £266 million in SDF is being provided to Cancer Alliances in 2024/25. Funding comprises two allocations: place-based, provided to all Alliances on a fair shares basis; and, targeted, provided to a selection of Alliances for agreed targeted projects. Cancer SDF is provided to Cancer Alliances via their lead ICBs to enable them to deliver on NHS-wide priorities for cancer, in line with their local delivery plans which are included in their funding agreement.

Cancer: Medical Treatments
Asked by: Baroness Finlay of Llandaff (Crossbench - Life peer)
Wednesday 16th October 2024

Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to ensure that NHS Trusts have the necessary funding and trained staff to deliver minimally invasive cancer therapies.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The adoption of new treatments, including increasing the number and availability of minimally invasive cancer treatments, into the National Health Service in England is generally the result of National Institute for Health and Care Excellence (NICE) guidance and commissioner decisions. Both NHS England and the integrated care boards (ICBs) are required to put in place access for any treatment that carries a positive recommendation from the Technology Appraisal programme, operated by the NICE.

Where treatments are approved by the NICE through the Technology Appraisals programme, the NHS is required to fund and make them available within agreed timescales, which vary by technology. Implementation of any NICE approvals will be supported by the service readiness assessment and the development of additional capacity where necessary.

We are committed to training the staff we need to get patients seen on time. The Government will make sure the NHS has the staff it needs to be there for all of us when we need it, including cancer patients.

Baroness Finlay of Llandaff mentioned

Select Committee Documents
Wednesday 6th November 2024 Oral Evidence - 2024-11-06 10:30:00+00:00 Holocaust Memorial Bill Select Committee (Lords) Found: BARONESS FINLAY OF LLANDAFF: Good morning. 8.
Wednesday 30th October 2024 Agendas and papers - Holocaust Memorial Bill: Select Committee Forward Programme Holocaust Memorial Bill Select Committee (Lords) Found: 018 ) Baroness Deech et al (HMB 011) 2.00pm Private Meeting 6 November 10.30am – 1.00pm Baroness
Wednesday 16th October 2024 Oral Evidence - House of Lords, Department for Business and Trade, Department for Business and Trade, and Department for Business and Trade Delegated Powers and Regulatory Reform Committee Found: Finlay of Llandaff ; Lord Goodman of Wycombe; Baroness Humphreys; Lord Rooker.
Wednesday 16th October 2024 Oral Evidence - House of Lords, Department for Business and Trade, Department for Business and Trade, and Department for Business and Trade Delegated Powers and Regulatory Reform Committee Found: Finlay of Llandaff; Lord Goodman of Wycombe; Baroness Humphreys; Lord Rooker.
Wednesday 16th October 2024 Scrutiny evidence - Promoter's Note on locus standi/right to be heard challenges with appendices Holocaust Memorial Bill Select Committee (Lords) Found: BARONESS FINLAY OF LLANDAFF ( COMMITTEES.PARLIAMENT.UK/HYBRIDBILLPETITION/251/DEFAULT/ ) – 2 JULY 2024

Bill Documents
Nov. 08 2024 HL Bill 18 Running list of amendments – 8 November 2024 Product Regulation and Metrology Bill [HL] 2024-26 Amendment Paper Found: BARONESS FINLAY OF LLANDAFF _ Clause 2, page 2, line 42, at end insert “and emergency services
Nov. 06 2024 HL Bill 18 Running list of amendments – 6 November 2024 Product Regulation and Metrology Bill [HL] 2024-26 Amendment Paper Found: BARONESS FINLAY OF LLANDAFF _ Clause 2, page 2, line 42, at end insert “and emergency services
Nov. 04 2024 HL Bill 18 Running list of amendments – 4 November 2024 Product Regulation and Metrology Bill [HL] 2024-26 Amendment Paper Found: BARONESS FINLAY OF LLANDAFF _ Clause 2, page 2, line 42, at end insert “and emergency services
Nov. 01 2024 HL Bill 18 Running list of amendments – 1 November 2024 Product Regulation and Metrology Bill [HL] 2024-26 Amendment Paper Found: BARONESS FINLAY OF LLANDAFF _ Clause 2, page 2, line 42, at end insert “and emergency services
Oct. 31 2024 HL Bill 18 Running list of amendments – 31 October 2024 Product Regulation and Metrology Bill [HL] 2024-26 Amendment Paper Found: BARONESS FINLAY OF LLANDAFF _ Clause 2, page 2, line 42, at end insert “and emergency services
Oct. 30 2024 HL Bill 18 Running list of amendments – 30 October 2024 Product Regulation and Metrology Bill [HL] 2024-26 Amendment Paper Found: BARONESS FINLAY OF LLANDAFF _ Clause 2, page 2, line 42, at end insert “and emergency services
Oct. 30 2024 Sixth Report of the Delegated Powers and Regulatory Reform Committee Product Regulation and Metrology Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 30 2024 HL Bill 18 Running list of amendments – 30 October 2024 Product Regulation and Metrology Bill [HL] 2024-26 Amendment Paper Found: BARONESS FINLAY OF LLANDAFF _ Clause 2, page 2, line 42, at end insert “and emergency services
Oct. 30 2024 Sixth Report of the Delegated Powers and Regulatory Reform Committee Institute for Apprenticeships and Technical Education (Transfer of Functions etc) Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 28 2024 HL Bill 18 Running list of amendments – 28 October 2024 Product Regulation and Metrology Bill [HL] 2024-26 Amendment Paper Found: BARONESS FINLAY OF LLANDAFF ★_ Clause 2, page 2, line 42, at end insert “and emergency services
Oct. 28 2024 Fourth Report of the Delegated Powers and Regulatory Reform Committee Product Regulation and Metrology Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 23 2024 Fifth Report of the Delegated Powers and Regulatory Reform Committee Passenger Railway Services (Public Ownership) Bill 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Education (Assemblies) Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Passenger Railway Services (Public Ownership) Bill 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Product Regulation and Metrology Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Consumer Products (Control of Biocides) Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Complications from Abortions (Annual Report) Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Environmental Targets (Public Authorities) Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Asylum Support (Prescribed Period) Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Public Authority Algorithmic and Automated Decision-Making Systems Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Refugees (Family Reunion) Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Listed Investment Companies (Classification etc) Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Mortgage Prisoners Inquiry Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Non-Consensual Sexually Explicit Images and Videos (Offences) Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Imprisonment for Public Protection (Re-sentencing) Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Palestine Statehood (Recognition) Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Universal Credit (Standard Allowance Entitlement of Care Leavers) Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Women, Peace and Security Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Oct. 15 2024 Second Report of the Delegated Powers and Regulatory Reform Committee Water (Special Measures) Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness
Sep. 05 2024 First Report of the Delegated Powers and Regulatory Reform Committee Support for Infants and Parents etc (Information) Bill [HL] 2024-26 Select Committee report Found: Baroness Chakrabarti The Earl of Lindsay Lord Cunningham of Felling Lord McLoughlin (Chair) Baroness

Baroness Finlay of Llandaff - Select Committee Information

Calendar
Wednesday 4th September 2024 10:30 a.m. Delegated Powers and Regulatory Reform Committee - Private Meeting View calendar
Wednesday 6th November 2024 10:30 a.m. Delegated Powers and Regulatory Reform Committee - Private Meeting View calendar
Wednesday 20th November 2024 10:30 a.m. Delegated Powers and Regulatory Reform Committee - Private Meeting View calendar
Wednesday 27th November 2024 10:30 a.m. Delegated Powers and Regulatory Reform Committee - Private Meeting View calendar
Wednesday 4th December 2024 10:30 a.m. Delegated Powers and Regulatory Reform Committee - Private Meeting View calendar
Wednesday 11th December 2024 10:30 a.m. Delegated Powers and Regulatory Reform Committee - Private Meeting View calendar
Friday 6th December 2024 9 a.m. Delegated Powers and Regulatory Reform Committee - Private Meeting View calendar

Select Committee Documents
Wednesday 16th October 2024 Oral Evidence - House of Lords, Department for Business and Trade, Department for Business and Trade, and Department for Business and Trade Delegated Powers and Regulatory Reform Committee
Wednesday 16th October 2024 Oral Evidence - House of Lords, Department for Business and Trade, Department for Business and Trade, and Department for Business and Trade Delegated Powers and Regulatory Reform Committee